For example, it has been shown that NFkB inhibition can delay cancer cell growth but does not necessarily lead to massive cell death in most solid tumors because of the coexistence of other, sometimes aberrant, anti-, or pro-apoptotic pathways independent of NFkB [19]. The gene discussed is NFKB1; the disease is cancer.